10122-550 : Mycapssa 20 mg Oral Capsule, Delayed Release
NDC: | 10122-550 |
Labeler: | Chiesi USA, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Mycapssa |
Dosage Form: | Oral Capsule, Delayed Release |
Application #: | NDA208232 |
Rev. Date: |
NDC Package Codes:
- 10122-550-28: 4 BLISTER PACK IN 1 DOSE PACK (10122‑550‑28) / 7 CAPSULE, DELAYED RELEASE IN 1 BLISTER PACK
Active Ingredients:
- Octreotide
Dosage Strength:
- 20 mg
Pharmaceutical Classes:
- Somatostatin Analog [EPC]
- Somatostatin Receptor Agonists [MoA]
Related Products:
Based on records with the same trade name.- 69880-120 Mycapssa 20 mg Oral Capsule, Delayed Release by Chiasma Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 10122-510Next: 10122-610 >
Related Discussions:
Hours between Octreotide inj's.
I'm supposed to be taking Octreotide inj's. three times a day. How many hours should I wait in between the inj... 1 reply
I'm supposed to be taking Octreotide inj's. three times a day. How many hours should I wait in between the inj... 1 reply
why with octreotide desperate
why can't you quit taking octreotide once you start taking it? What is carcinoid crisis?...
why can't you quit taking octreotide once you start taking it? What is carcinoid crisis?...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.